Epa And Dha Market Is Estimated To Witness High Growth Owing To Opportunity Of Rising Demand From Food Supplements Secto

Comments · 19 Views

EPA and DHA are polyunsaturated fatty acids that provide numerous health benefits. They help reduce inflammation, improve heart health, and support brain and eye development. EPA and DHA are widely used in dietary supplements to promote overall health and wellness. The growing health-conscious consumer base is increasingly incorporating fish oil supplements, algal oil, krill oil in their daily diet for added nutritional support. Widening applications of these fatty acids in infant formula are also contributing to the growing demand.

 

The global EPA And DHA Market Size is estimated to be valued at US$ 1853.38 Mn  in 2023 and is expected to exhibit a CAGR of 23%  over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
Rising Demand from Food Supplements Sector
There is high demand for EPA and DHA in food supplements due to their proven health benefits. According to estimates, over 80% of the global EPA and DHA consumption is through dietary supplements due to easier dosage and high convenience. Supplement form makes it simple for time-pressed consumers to get adequate amounts of these fatty acids. Furthermore, surging health issues like cardiovascular diseases, depression are driving individuals towards preventive medication through supplements. Increasing awareness about the role of EPA and DHA in brain and heart functions is acting as a major driver for their use in dietary supplements. The rising demand for supplements incorporating EPA and DHA represents a major market opportunity for manufacturers.

Porter's Analysis
Threat of new entrants: The EPA and DHA market has moderate threat of new entrants due to relatively high capital requirements for R&D, processing facilities and distribution channels.
Bargaining power of buyers: Buyers in the EPA and DHA market have moderate bargaining power due to the availability of substitute products. However, health benefits of EPA and DHA gives some bargaining power to existing players.
Bargaining power of suppliers: The bargaining power of suppliers is low to moderate since raw materials for EPA and DHA such as fish oil areavailable and suppliers are numerous.
Threat of new substitutes: Potential threat from new substitutes is moderate as manufacturers are exploring alternative sources of omega-3 such as algal oil.
Competitive rivalry: The EPA and DHA market has high competitive rivalry due to presence of numerous global and regional players.

SWOT Analysis
Strength: EPA and DHA have several health benefits such as reducing inflammation and risks of heart disease. Growing health conscious population boosts demand.
Weakness: High dependence on fish stocks for raw materials increases supply risks. Premium pricing of EPA and DHA products limits mass adoption.
Opportunity: Rising lifestyle diseases and aging population in developed nations increases preventive healthcare spending on EPA and DHA supplements. Algal oils provide an alternative source of supply.
Threats: Stricter environment regulations can reduce fish stocks. Substitutes from plant and nut sources gain market share.

Key Takeaways
The global EPA And DHA Market Size is expected to witness high growth led by growth in the Asia Pacific region. The global EPA and DHA Market is estimated to be valued at US$ 1853.38 Mn  in 2023 and is expected to exhibit a CAGR of 23%  over the forecast period 2023 to 2030.

The Asia Pacific EPA and DHA market accounts for over 35% of the global market share in 2023 and is expected to grow at the fastest pace during the forecast period. China, Japan and India are the key markets in the region attributed to rising health awareness, increasing disposable incomes and high prevalence of lifestyle diseases such as diabetes and hypertension.


Key players operating in the EPA and DHA market are Broadcom Inc., Sicoya GMBH, GlobalFoundries Inc., Intel Corporation, Juniper Networks Inc., Cisco Systems Inc., IBM Corporation, and NeoPhotonics Corporation. Rising focus on R&D of more sustainable algal sources of omega-3 fatty acids is expected to increase substitute threat for fish oil sources during the forecast period. Adoption of EPA and DHA products is also expected to gain traction in infant nutrition and pet food applications.

 

Get More Insights On This Topic:  https://www.newsanalyticspro.com/epa-and-dha-market-is-expected-to-be-flourished-by-growing-demand/

disclaimer
Comments